Is the management of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) based on the extent of the affected surface area or the degree of epidermal detachment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Based on Epidermal Detachment

The management of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is based on the extent of epidermal detachment rather than the affected surface area, as this figure has greater prognostic value. 1

Classification Based on Epidermal Detachment

  • SJS is defined as epidermal detachment of <10% body surface area (BSA) plus widespread purpuric macules or flat atypical targets 1
  • Overlap SJS-TEN is defined as detachment of 10-30% BSA plus widespread purpuric macules or flat atypical targets 1
  • TEN is defined as detachment of >30% BSA with or without widespread purpuric macules or target lesions 1

Clinical Assessment of Epidermal Detachment

  • When assessing patients with suspected SJS/TEN, both the extent of erythema AND the extent of epidermal detachment should be recorded separately on a body map 1
  • Epidermal detachment includes both:
    • Already detached epidermis (visible erosions and blisters) 1
    • Detachable epidermis (areas with positive Nikolsky sign) 1
  • The Nikolsky sign is demonstrated when gentle lateral pressure causes lesional, detachable epidermis to slide over the dermis 1

Prognostic Significance

  • The percentage of epidermal detachment is used in the SCORTEN scoring system to predict mortality 1
  • Mortality rates increase significantly with greater epidermal detachment:
    • SJS: 1-5% mortality 2, 3
    • TEN: 25-35% mortality 2, 3

Management Implications Based on Detachment

  • Patients with >10% BSA epidermal detachment should be admitted without delay to a burn center or ICU with experience in treating SJS/TEN 1
  • The approach to wound management differs based on the extent of epidermal detachment:
    • Conservative approach: For limited detachment 1
    • Surgical approach: May be considered for detachment >30% BSA with clinical deterioration 1

Documentation and Monitoring

  • Use the Lund and Browder chart to estimate the percentage of BSA involved 1
  • Document both erythema and epidermal detachment separately, as they represent different aspects of the disease 1
  • Monitor for progression of detachment, as this indicates worsening disease 1

Common Pitfalls to Avoid

  • Do not rely solely on the extent of erythema for classification or prognosis, as this can lead to underestimation of disease severity 1
  • Do not confuse SJS/TEN with other blistering disorders such as erythema multiforme major, which has different clinical features and causes 1, 4
  • Avoid delaying transfer to specialized care when epidermal detachment exceeds 10% BSA, as this increases mortality risk 1
  • Remember that epidermal detachment may progress rapidly, requiring frequent reassessment 1, 5

Differential Diagnosis Considerations

  • Staphylococcal scalded skin syndrome has a more superficial level of skin cleavage and can be differentiated on skin biopsy 1, 2
  • Immunobullous disorders like pemphigus vulgaris and bullous pemphigoid require immunofluorescence studies for differentiation 4, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Orphanet journal of rare diseases, 2010

Research

Stevens-Johnson syndrome and toxic epidermal necrolysis.

Chemical immunology and allergy, 2012

Guideline

Histopathological Features and Differential Diagnosis of Erythema Multiforme

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.